{"date":"2025-10-09","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6796-2025-10-09-2039-1oq71u9","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"20:39:15","subject":"本公司電子拋棄式支氣管鏡ECB100通過日本第二類醫療器材審查","clause":"第51款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-10-09 20:39，「本公司電子拋棄式支氣管鏡ECB100通過日本第二類醫療器材審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-10-09-1842-1sm5xbj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-09","time":"18:42:31","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-10-09 18:42，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-10-09-1825-xalqm9","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-09","time":"18:25:10","subject":"(補充114/8/25公告)子公司合富(中國)醫療科技股份有限公司，擬投資明基醫院集團股份有限公司股權案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-10-09 18:25，「(補充114/8/25公告)子公司合富(中國)醫療科技股份有限公司，擬投資明基醫院集團股份有限公司股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-10-09-1749-66hqtw","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"17:49:09","subject":"公告本公司第3次買回庫藏股期間屆滿及執行情形","clause":"第35款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-10-09 17:49，「公告本公司第3次買回庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-10-09-1705-7x39bd","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-10-09","time":"17:05:17","subject":"本公司董事會通過授權總經理簽署海外代理合約","clause":"第44款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-10-09 17:05，「本公司董事會通過授權總經理簽署海外代理合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-10-09-1653-5rax5d","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-10-09","time":"16:53:58","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-10-09 16:53，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-10-09-1653-1gym387","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-10-09","time":"16:53:35","subject":"公告本公司董事會決議辦理初次上櫃前現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-10-09 16:53，「公告本公司董事會決議辦理初次上櫃前現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-10-09-1642-19mucna","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"16:42:30","subject":"公告本公司董事會決議擬投資佳世達集團BenQ BM Holding Cayman Corp.","clause":"第20款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-10-09 16:42，「公告本公司董事會決議擬投資佳世達集團BenQ BM Holding Cayman Corp.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-10-09-1634-5rax5d","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"16:34:57","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第11款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-10-09 16:34，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-10-09-1632-yfmypb","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"16:32:14","subject":"公告本公司董事會通過114年第三季個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-10-09 16:32，「公告本公司董事會通過114年第三季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-10-09-1626-1as0m4d","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"16:26:58","subject":"本公司股票改列上市前現金增資員工認購股款催繳事宜","clause":"第51款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-10-09 16:26，「本公司股票改列上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-10-09-1600-jeskrg","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-10-09","time":"16:00:21","subject":"公告本公司114年現金增資發行新股委託代收股款及存儲專戶行庫","clause":"第9款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-10-09 16:00，「公告本公司114年現金增資發行新股委託代收股款及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-10-09-1532-1uhskx3","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-10-09","time":"15:32:34","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-10-09 15:32，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-10-09-1529-jm1tyr","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-10-09","time":"15:29:01","subject":"公告本公司董事會追認修訂114年度員工認股權憑證發行及認股辦法","clause":"第9款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-10-09 15:29，「公告本公司董事會追認修訂114年度員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-10-09-1434-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"14:34:15","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-10-09 14:34，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-10-09-1433-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-10-09","time":"14:33:49","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-10-09 14:33，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-10-09-1332-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-10-09","time":"13:32:42","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」墨西哥專利核准通知書。","clause":"第53款","fact_date":"2025-10-09","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-10-09 13:32，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}